Use of CA-125 to Define Progression of Ovarian Cancer in Patients With Persistently Elevated Levels
- 15 October 2001
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 19 (20), 4054-4057
- https://doi.org/10.1200/jco.2001.19.20.4054
Abstract
PURPOSE: To determine an accurate definition for progression of ovarian cancer in patients with a persistently elevated serum CA-125. PATIENTS AND METHODS: A retrospective analysis was performed on...Keywords
This publication has 6 references indexed in Scilit:
- Re: New Guidelines to Evaluate the Response to Treatment in Solid Tumors [Ovarian Cancer]JNCI Journal of the National Cancer Institute, 2000
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI Journal of the National Cancer Institute, 2000
- Defining progression of ovarian carcinoma during follow-up according to CA 125: A North Thames Ovary Group studyAnnals of Oncology, 1996
- Savings obtained by CA-125 measurements during therapy for ovarian carcinomaEuropean Journal Of Cancer, 1992
- The role of CA 125 in the early diagnosis of progressive disease in ovarian cancerAnnals of Oncology, 1990
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983